WELCOME
What is clinical research? ‘ CLINICAL’ means: ‘Treatment of patients’ ‘ RESEARCH’ means: ‘Systematic investigation & study in order to establish facts & reach new conclusions’
A clinical trial (also clinical research) is a research study in human volunteers to answer specific health questions. Carefully conducted clinical trials are the safest and fastest way to find treatments that work in people and ways to improve health. Clinical trials are the final step in a long research process that include preliminary laboratory research and experiment.
Types of clinical trial Interventional trials determine whether experimental treatments or new ways of using known therapies are safe and effective under controlled environments. Observational trials address health issues in large groups of people or populations in natural settings.
Phases of drug development Identification of new molecule Screening of biological activity/experiment design Preformulation  Formulation Stability testing.
Phases of Drug Development Steps prior to human trials: Preclinical (nonclinical).  Animal and in vitro studies. A study to test a drug procedure or other medical treatment in animals. Preclinical studies are required before clinical trials can be started. Investigational new drug application (IND) or Investigational device exemption (IDE) for the FDA
Basis for phased drug development Safety Pharmacology Efficacy
Phases of Drug Development Phase 1: First studies in human. Usually involve small groups of healthy volunteers or patients with particular disease – 20 - 80. Short duration. Provide preliminary safety and tolerability evaluation. Establish pharmacokinetic and pharmacodynamic profiles of the drug
Phases of Drug Development Evaluate efficacy and short-term safety of the drug. small groups of patients with disease under study. 100-300 subjects Have well defined eligibility criteria Determine dosing Duration –couple of months to 2 years Phase 2:
Phases of Drug Development Phase 3  Larger, well-controlled trials with larger groups of subjects. Eligibility criteria usually broader Simulate the actual treatment condition Establishes safety and efficacy profile in broad sample. Results used in marketing application and official product labeling.
Phases of Drug Development Phase 4: Conducted after marketing approval of drug. -Post marketing studies sometimes designed to  differentiate the drug from competitors and  demonstrate  health economic benefits. Include post registration usage studies and post-marketing surveillance studies.
Key stake holders Study sponsor Investigator and site personnel Monitors IRB/IEC Study subjects Hospital administration Regulator
Key documents in Clinical research Investigators brochure Study protocol Informed consent form Case report form Source documents Clinical study report
International Conference on Harmonisation Agreement between the united states, Japan and European  Union Describes Good Clinical Practices The main agenda of ICH-GCP is to protect human subjects and ensure credibility of data
Why Career in Clinical Research? Fastest growing segment in the healthcare / pharmaceutical industry Excellent Opportunity to Develop Combination of Technical and  Management Skill Development Part of the Global Growth Opportunity Wider Job Horizon Rapidly Growing Opportunities…  (internal and external) Higher Salaries Higher Job Satisfaction Continuous Training Opportunities Overseas Job Opportunities
India –Hub of global clinical research India is one of the top 3 countries where companies plan to spend the most R&D dollars over the next three years Over 30 CRO’s offer phase 1 to 4 trials complying with ICH-GCP guidelines Over US$500 million FDI expected in the next 18months With 100 hospitals serving as sites for clinical trials ,India is emerging as one of the fastest recruiter of subjects across the world.
Advantages of  India The clinical community populated with English speaking ,western –trained graduates Sophisticated technological infrastructure 100 million plus English speaking /trained professionals  Over 2 million science graduates Large pool of treatment naïve patients from multiethnic and multiracial backgrounds Better patient recruitment, retention and compliance
Cost effective operations Participants generally benefit ,as the trials conducted in India mostly in phase 2 -4, provide improved care and cost savings as procedures and drugs are provided at no charge Higher GMP/GLP/GCP compliance Maximum number of approved GMP plants outside USA Excellent quality management ,technology and infrastructure Increasing presence of all pharma majors ,CROs and also in-house CROs set up by leading pharma companies Strong IT industry availability of IT skilled manpower
Regulatory frame work Positive regulatory environment –protocols approved by DCGI/ Schedule Y CDSCO (Central Drugs Standard Control Organization) to regulate Clinical research Further strengthening of environment by setting up National Drug Authority Intellectual property protection As of January  2005 ,recognize product patents from 1995 to present Clinical trial protocol time is reducing  Duty free import of clinical trial supplies Easier drug importation procedure ICMR guidelines on the safety of Human Subjects
India’s vital clinical statistics Cancer  : 3 million Diabetes  : 34 million HIV  : 8-10 million Epilepsy  : 8 million Hypertension  : 150 million Schizophrenia  : 1 million Asthma  : 40 million Alzheimer’s  : 1.5 million Cardiac related deaths  : 2 million Recruits for genetic studies 600,000 practicing physicians 14,000 hospitals 700,000 beds 17,000 medical graduates per year
Indian Market For Clinical Research 2002 Industry Spending on  CRO Services and Investigator Grants $30  million Market Size in 2005-06   $200 million Estimated Market Size in 2007 $450 million Estimated Market Size in 2008  $600 million 2012Projected Industry Spending on CRO Services and Investigator Grants  $2 billion
Some Pharma Companies in Clinical Research Chiron, Mumbai  Astra Zeneca Pharma India Ltd, Bangalore  Astra Zeneca Foundation, Bangalore  AventisPasteur, Delhi  Pfizer Ltd, Mumbai  Pfizer Biometrics, Mumbai  Altana(Zydus), Mumbai  Eli Lilly, Delhi  Boston Scientific, Delhi  Hospira, Delhi  Merck ,Delhi  Sanofi Aventis Syntho Lab, Mumbai  GSK, Glaxo SmithKline Pharmaceuticals Ltd,Mumbai  Novartis International Clinical Development Center,  Novartis Pharma, Mumbai  Roche,Mumbai
Key CROs in India Quintiles Ahmadabad / Bangalore Synchron Ahmedabad /Bangalore Lambda Ahmedabad Siro Clinpharm Mumbai I-Gate Mumbai Reliance Clinical Services Mumbai PPD Mumbai Onmnicare Bangalore ICON Bangalore Clin Trac Bangalore PharmaNet  Bangalore Pharm-Olam Bangalore Lotus Labs Bangalore Vimta Hyderabad GVK  Hyderabad BioServe Clinical Research Hyderabad Apothecaries Delhi
Types of Jobs Clinical Monitors / CRAs Clinical Research Coordinators / Site Coordinators Drug Safety Personnel Project Personnel Medical Monitors Regulatory Affairs Monitors Medical Writers Quality Control / Assurance Personnel Data Management Personnel Statisticians Scientists Lab Personnel Management & Support Personnel
Types of Employers Pharmaceutical Companies Contract Research Organization  Hospitals Non Government Organization WHO
Key cities in India for clinical research Delhi &NCR Region  Mumbai Pune Ahmedabad Hyderabad Bangalore Chennai
Challenges of current CR Industry Major gap in Demand & Supply of trained  manpower – An unmet need  By 2012 Indian market would be over US$2 billion, and would continue to grow at rapid pace. Over 75 CROs & 60 In-house Pharmaceutical Clinical Research & R&D Facilities in India and increasing Current trained manpower demand in the field of Clinical Research is over 10,000 trained personnel per annum.
By 2012 over 50,000 certified/trained  professionals will be required. The current facilities are able to train only  1,500 professionals.  Employers required well trained professionals.  very rapid growth in number and size of company  Lack of specialization Spectrum of skills required is in scarcity  Limited pool of experienced people Employee retention Continuous  training
CLINIMINDS
“ Committed to provide highest quality training ,education &management solutions and develop superior human resource for the global clinical research industry”.
About Cliniminds Cliniminds was established in the year 2004 by a group  of Senior Professionals from Pharmaceutical, Clinical Research & Healthcare  industry. Two brands – Cliniminds & Mediminds were established to provide vocational and professional education and training in the clinical research, healthcare & pharmaceutical areas. To provide opportunities to fresh graduates or working executives aspiring to build career in the booming Clinical Research / Healthcare/ Pharmaceutical industry. To provide continuing education, Professional development, and vocational skills enhancement Programs for Clinical Research / Healthcare / Pharmaceutical professionals
Features of Cliniminds Cliniminds is an innovative training company providing a wide range of clinical research training solutions to the students, pharmaceutical companies, CRO s and healthcare companies in India and other part of the world Cliniminds-Academy for clinical research training and management, offers wide range of full time, part time, class room, online and distance learning certificate /diploma programs, workshops &seminars Cliniminds can help to achieve the level of expertise required , through user-friendly and cost effective training programs Restricted number of students  100 % placement assistance to all students All Cliniminds programs are certified and accredited by the Pharmaceutical society of India and Cliniminds (ISO 9001/2000 certified academy) jointly.
Cliniminds Key Team Members Kamal Shahani – Consultant/Industry expert/Trainer Dr. Srinkant Tadipatri, Clinical Research Specialist from United States, ex Pfizer Dr. Suneet Sood, Professor, leading international medical school Dr. U. Kapoor, Senior Manager, Clinical Research Dr. Deepak Bunger, Clinical Investigator, PGI Dr. Amit Bhatt, CEO, Nexus CRO Mr. Vatsal Acharya, Industry Specialist from leading MNC Dr. G.S. Arora, Industry Specialist from leading MNC & Former Professor of Clinical Research Dr. Ramesh C, Princpal, Pharmacy College, Hyderabad Ms. Pooja Saxena, Senior CRA, leading CRA
Our Core Areas Clinical Research/Medical/Healthcare Educational  Training Programs Course Content Development Management Development  Programs Placement Services Business & Consulting Services
Programs offered by Cliniminds Classroom Programs, Distance & Online Advance Post Graduate Program in Clinical Research  Post Graduate Program in Clinical Trial Management Post Graduate Program in Clinical Data Management
Distance & On - Line Programs Post Graduate Diploma in Clinical Trial Management Advanced Post Graduate program in Clinical Research Certified program in Clinical Research Post graduate program in Clinical Data Management Post Graduate program in Pharmacovigilence  Post graduate program in Conducting &Managing BA/BE studies  Certificate Program in Conducting & Managing Clinical Trials for Cancer Patients Post Graduate program in Quality assurance in clinical research Post graduate program in Regulatory Affairs Post graduate program in clinical research for nurses Post Graduate Program for Investigators & Site Personnel Post Graduate Program for CRAs/Monitors
E-Learning Programs-Video Conference Class Advanced PG Program in Clinical Research PG Program in Basics of Biostatistics
Workshops &corporate trainings Cliniminds conducts regular interactive workshops on clinical research on regular basis Providing in house training solution for corporates Certificates are provided at the end of the workshops Cost efficient –value for money Customization of workshops as per client needs
Eligiblity All from Science backgrounds MD,MS,MBBS,BDS,BHMS,BAMS,Grad-uate /Post Graduate Degree in Science, Pharmacology, Pharmacy, Life sciences , Medical laboratory ,Nursing, Biochemistry, Microbiology ,Biotechnology. All professionals working with Pharmaceutical companies or CROs
Methodology Regular classes Printed training modules Workshops Web based testing and examinations Onsite training ICH GCP guidelines and covers schedule Y and CFR 21 compliant programs
Educational loans –HDFC Bank All our programs have been approved by the HDFC BANK for the purpose of educational loans for the students
Cliniminds (Unit of Tenet Health Edutech Pvt. Ltd. ) No. 420, 1st Floor, 9th Main, Banashankari 2nd Stage, Bangalore - 560070 Mobile: +91-96636-91388 Email :  bangalore @cliniminds.com Website : http://www.cliniminds.com
Thank you

Clinical Research Presentation

  • 1.
  • 2.
    What is clinicalresearch? ‘ CLINICAL’ means: ‘Treatment of patients’ ‘ RESEARCH’ means: ‘Systematic investigation & study in order to establish facts & reach new conclusions’
  • 3.
    A clinical trial(also clinical research) is a research study in human volunteers to answer specific health questions. Carefully conducted clinical trials are the safest and fastest way to find treatments that work in people and ways to improve health. Clinical trials are the final step in a long research process that include preliminary laboratory research and experiment.
  • 4.
    Types of clinicaltrial Interventional trials determine whether experimental treatments or new ways of using known therapies are safe and effective under controlled environments. Observational trials address health issues in large groups of people or populations in natural settings.
  • 5.
    Phases of drugdevelopment Identification of new molecule Screening of biological activity/experiment design Preformulation Formulation Stability testing.
  • 6.
    Phases of DrugDevelopment Steps prior to human trials: Preclinical (nonclinical). Animal and in vitro studies. A study to test a drug procedure or other medical treatment in animals. Preclinical studies are required before clinical trials can be started. Investigational new drug application (IND) or Investigational device exemption (IDE) for the FDA
  • 7.
    Basis for phaseddrug development Safety Pharmacology Efficacy
  • 8.
    Phases of DrugDevelopment Phase 1: First studies in human. Usually involve small groups of healthy volunteers or patients with particular disease – 20 - 80. Short duration. Provide preliminary safety and tolerability evaluation. Establish pharmacokinetic and pharmacodynamic profiles of the drug
  • 9.
    Phases of DrugDevelopment Evaluate efficacy and short-term safety of the drug. small groups of patients with disease under study. 100-300 subjects Have well defined eligibility criteria Determine dosing Duration –couple of months to 2 years Phase 2:
  • 10.
    Phases of DrugDevelopment Phase 3 Larger, well-controlled trials with larger groups of subjects. Eligibility criteria usually broader Simulate the actual treatment condition Establishes safety and efficacy profile in broad sample. Results used in marketing application and official product labeling.
  • 11.
    Phases of DrugDevelopment Phase 4: Conducted after marketing approval of drug. -Post marketing studies sometimes designed to differentiate the drug from competitors and demonstrate health economic benefits. Include post registration usage studies and post-marketing surveillance studies.
  • 12.
    Key stake holdersStudy sponsor Investigator and site personnel Monitors IRB/IEC Study subjects Hospital administration Regulator
  • 13.
    Key documents inClinical research Investigators brochure Study protocol Informed consent form Case report form Source documents Clinical study report
  • 14.
    International Conference onHarmonisation Agreement between the united states, Japan and European Union Describes Good Clinical Practices The main agenda of ICH-GCP is to protect human subjects and ensure credibility of data
  • 15.
    Why Career inClinical Research? Fastest growing segment in the healthcare / pharmaceutical industry Excellent Opportunity to Develop Combination of Technical and Management Skill Development Part of the Global Growth Opportunity Wider Job Horizon Rapidly Growing Opportunities… (internal and external) Higher Salaries Higher Job Satisfaction Continuous Training Opportunities Overseas Job Opportunities
  • 16.
    India –Hub ofglobal clinical research India is one of the top 3 countries where companies plan to spend the most R&D dollars over the next three years Over 30 CRO’s offer phase 1 to 4 trials complying with ICH-GCP guidelines Over US$500 million FDI expected in the next 18months With 100 hospitals serving as sites for clinical trials ,India is emerging as one of the fastest recruiter of subjects across the world.
  • 17.
    Advantages of India The clinical community populated with English speaking ,western –trained graduates Sophisticated technological infrastructure 100 million plus English speaking /trained professionals Over 2 million science graduates Large pool of treatment naïve patients from multiethnic and multiracial backgrounds Better patient recruitment, retention and compliance
  • 18.
    Cost effective operationsParticipants generally benefit ,as the trials conducted in India mostly in phase 2 -4, provide improved care and cost savings as procedures and drugs are provided at no charge Higher GMP/GLP/GCP compliance Maximum number of approved GMP plants outside USA Excellent quality management ,technology and infrastructure Increasing presence of all pharma majors ,CROs and also in-house CROs set up by leading pharma companies Strong IT industry availability of IT skilled manpower
  • 19.
    Regulatory frame workPositive regulatory environment –protocols approved by DCGI/ Schedule Y CDSCO (Central Drugs Standard Control Organization) to regulate Clinical research Further strengthening of environment by setting up National Drug Authority Intellectual property protection As of January 2005 ,recognize product patents from 1995 to present Clinical trial protocol time is reducing Duty free import of clinical trial supplies Easier drug importation procedure ICMR guidelines on the safety of Human Subjects
  • 20.
    India’s vital clinicalstatistics Cancer : 3 million Diabetes : 34 million HIV : 8-10 million Epilepsy : 8 million Hypertension : 150 million Schizophrenia : 1 million Asthma : 40 million Alzheimer’s : 1.5 million Cardiac related deaths : 2 million Recruits for genetic studies 600,000 practicing physicians 14,000 hospitals 700,000 beds 17,000 medical graduates per year
  • 21.
    Indian Market ForClinical Research 2002 Industry Spending on CRO Services and Investigator Grants $30 million Market Size in 2005-06 $200 million Estimated Market Size in 2007 $450 million Estimated Market Size in 2008 $600 million 2012Projected Industry Spending on CRO Services and Investigator Grants $2 billion
  • 22.
    Some Pharma Companiesin Clinical Research Chiron, Mumbai Astra Zeneca Pharma India Ltd, Bangalore Astra Zeneca Foundation, Bangalore AventisPasteur, Delhi Pfizer Ltd, Mumbai Pfizer Biometrics, Mumbai Altana(Zydus), Mumbai Eli Lilly, Delhi Boston Scientific, Delhi Hospira, Delhi Merck ,Delhi Sanofi Aventis Syntho Lab, Mumbai GSK, Glaxo SmithKline Pharmaceuticals Ltd,Mumbai Novartis International Clinical Development Center, Novartis Pharma, Mumbai Roche,Mumbai
  • 23.
    Key CROs inIndia Quintiles Ahmadabad / Bangalore Synchron Ahmedabad /Bangalore Lambda Ahmedabad Siro Clinpharm Mumbai I-Gate Mumbai Reliance Clinical Services Mumbai PPD Mumbai Onmnicare Bangalore ICON Bangalore Clin Trac Bangalore PharmaNet Bangalore Pharm-Olam Bangalore Lotus Labs Bangalore Vimta Hyderabad GVK Hyderabad BioServe Clinical Research Hyderabad Apothecaries Delhi
  • 24.
    Types of JobsClinical Monitors / CRAs Clinical Research Coordinators / Site Coordinators Drug Safety Personnel Project Personnel Medical Monitors Regulatory Affairs Monitors Medical Writers Quality Control / Assurance Personnel Data Management Personnel Statisticians Scientists Lab Personnel Management & Support Personnel
  • 25.
    Types of EmployersPharmaceutical Companies Contract Research Organization Hospitals Non Government Organization WHO
  • 26.
    Key cities inIndia for clinical research Delhi &NCR Region Mumbai Pune Ahmedabad Hyderabad Bangalore Chennai
  • 27.
    Challenges of currentCR Industry Major gap in Demand & Supply of trained manpower – An unmet need By 2012 Indian market would be over US$2 billion, and would continue to grow at rapid pace. Over 75 CROs & 60 In-house Pharmaceutical Clinical Research & R&D Facilities in India and increasing Current trained manpower demand in the field of Clinical Research is over 10,000 trained personnel per annum.
  • 28.
    By 2012 over50,000 certified/trained professionals will be required. The current facilities are able to train only 1,500 professionals. Employers required well trained professionals. very rapid growth in number and size of company Lack of specialization Spectrum of skills required is in scarcity Limited pool of experienced people Employee retention Continuous training
  • 29.
  • 30.
    “ Committed toprovide highest quality training ,education &management solutions and develop superior human resource for the global clinical research industry”.
  • 31.
    About Cliniminds Clinimindswas established in the year 2004 by a group of Senior Professionals from Pharmaceutical, Clinical Research & Healthcare industry. Two brands – Cliniminds & Mediminds were established to provide vocational and professional education and training in the clinical research, healthcare & pharmaceutical areas. To provide opportunities to fresh graduates or working executives aspiring to build career in the booming Clinical Research / Healthcare/ Pharmaceutical industry. To provide continuing education, Professional development, and vocational skills enhancement Programs for Clinical Research / Healthcare / Pharmaceutical professionals
  • 32.
    Features of ClinimindsCliniminds is an innovative training company providing a wide range of clinical research training solutions to the students, pharmaceutical companies, CRO s and healthcare companies in India and other part of the world Cliniminds-Academy for clinical research training and management, offers wide range of full time, part time, class room, online and distance learning certificate /diploma programs, workshops &seminars Cliniminds can help to achieve the level of expertise required , through user-friendly and cost effective training programs Restricted number of students 100 % placement assistance to all students All Cliniminds programs are certified and accredited by the Pharmaceutical society of India and Cliniminds (ISO 9001/2000 certified academy) jointly.
  • 33.
    Cliniminds Key TeamMembers Kamal Shahani – Consultant/Industry expert/Trainer Dr. Srinkant Tadipatri, Clinical Research Specialist from United States, ex Pfizer Dr. Suneet Sood, Professor, leading international medical school Dr. U. Kapoor, Senior Manager, Clinical Research Dr. Deepak Bunger, Clinical Investigator, PGI Dr. Amit Bhatt, CEO, Nexus CRO Mr. Vatsal Acharya, Industry Specialist from leading MNC Dr. G.S. Arora, Industry Specialist from leading MNC & Former Professor of Clinical Research Dr. Ramesh C, Princpal, Pharmacy College, Hyderabad Ms. Pooja Saxena, Senior CRA, leading CRA
  • 34.
    Our Core AreasClinical Research/Medical/Healthcare Educational Training Programs Course Content Development Management Development Programs Placement Services Business & Consulting Services
  • 35.
    Programs offered byCliniminds Classroom Programs, Distance & Online Advance Post Graduate Program in Clinical Research Post Graduate Program in Clinical Trial Management Post Graduate Program in Clinical Data Management
  • 36.
    Distance & On- Line Programs Post Graduate Diploma in Clinical Trial Management Advanced Post Graduate program in Clinical Research Certified program in Clinical Research Post graduate program in Clinical Data Management Post Graduate program in Pharmacovigilence Post graduate program in Conducting &Managing BA/BE studies Certificate Program in Conducting & Managing Clinical Trials for Cancer Patients Post Graduate program in Quality assurance in clinical research Post graduate program in Regulatory Affairs Post graduate program in clinical research for nurses Post Graduate Program for Investigators & Site Personnel Post Graduate Program for CRAs/Monitors
  • 37.
    E-Learning Programs-Video ConferenceClass Advanced PG Program in Clinical Research PG Program in Basics of Biostatistics
  • 38.
    Workshops &corporate trainingsCliniminds conducts regular interactive workshops on clinical research on regular basis Providing in house training solution for corporates Certificates are provided at the end of the workshops Cost efficient –value for money Customization of workshops as per client needs
  • 39.
    Eligiblity All fromScience backgrounds MD,MS,MBBS,BDS,BHMS,BAMS,Grad-uate /Post Graduate Degree in Science, Pharmacology, Pharmacy, Life sciences , Medical laboratory ,Nursing, Biochemistry, Microbiology ,Biotechnology. All professionals working with Pharmaceutical companies or CROs
  • 40.
    Methodology Regular classesPrinted training modules Workshops Web based testing and examinations Onsite training ICH GCP guidelines and covers schedule Y and CFR 21 compliant programs
  • 41.
    Educational loans –HDFCBank All our programs have been approved by the HDFC BANK for the purpose of educational loans for the students
  • 42.
    Cliniminds (Unit ofTenet Health Edutech Pvt. Ltd. ) No. 420, 1st Floor, 9th Main, Banashankari 2nd Stage, Bangalore - 560070 Mobile: +91-96636-91388 Email : bangalore @cliniminds.com Website : http://www.cliniminds.com
  • 43.